Evidence map›Paper›PMID 34965416›Full record

ArticleCell reports2021

Assessing kinetics and recruitment of DNA repair factors using high content screens.

Barbara Martinez-Pastor, Giorgia G Silveira, Thomas L Clarke, Dudley Chung, Yuchao Gu, Claudia Cosentino, Lance S Davidow, Gadea Mata, Sylvana Hassanieh, Jayme Salsman and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Zinc finger proteins: guardians of genome stability.Frontiers in cell and developmental biology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 4 countries.

Barbara Martinez-PastorThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain. Electronic address: bmartinezp@cnio.es.
Giorgia G SilveiraThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Thomas L ClarkeThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Dudley ChungDepartment of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Yuchao GuSchool of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao 266003, China.
Claudia CosentinoThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Lance S DavidowDepartment of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Gadea MataConfocal Microscopy Unit, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Sylvana HassaniehThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Jayme SalsmanDepartment of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Alberto CicciaDepartment of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA.
Narkhyun BaeDepartment of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA.
Mark T BedfordDepartment of Epigenetics & Molecular Carcinogenesis, M.D.Anderson Cancer Center, University of Texas, Smithville, TX 78957, USA.
Diego MegiasConfocal Microscopy Unit, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Lee L RubinDepartment of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Alejo EfeyanMolecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Graham DellaireDepartment of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada; Beatrice Hunter Cancer Research Institute, Halifax, NS B3H 4R2, Canada. Electronic address: dellaire@dal.ca.
Raul MostoslavskyThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address: rmostoslavsky@mgh.harvard.edu.
Broad Institute · USCentro de Investigación del Cáncer · ESColumbia University Irving Medical Center · USDalhousie University · CAHarvard University · USMassachusetts General Hospital · USBeatrice Hunter Cancer Research Institute · CAHarvard Stem Cell Institute · USOcean University of China · CNSpanish National Cancer Research Centre · ESThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KAHN, BARBARA B. · 2000 to 2019
$31.4M
Transcriptional regulation by the DNA damage responseR01GM117064 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CICCIA, ALBERTO · 2016 to 2019
$1.2M
A high throughput assay to identify novel chromatin factors that regulate DNA repairR21ES027931 · NIEHS · MASSACHUSETTS GENERAL HOSPITAL · PI MOSTOSLAVSKY, RAUL · 2018 to 2019
$463k
NCI NIH HHS P30 CA013696NIDDK NIH HHS P30 DK040561NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK057521NIEHS NIH HHS R21 ES027931NIGMS NIH HHS R01 GM117064
6 · The paper itself

Abstract

Repair of genetic damage is coordinated in the context of chromatin, so cells dynamically modulate accessibility at DNA breaks for the recruitment of DNA damage response (DDR) factors. The identification of chromatin factors with roles in DDR has mostly relied on loss-of-function screens while lacking robust high-throughput systems to study DNA repair. In this study, we have developed two high-throughput systems that allow the study of DNA repair kinetics and the recruitment of factors to double-strand breaks in a 384-well plate format. Using a customized gain-of-function open-reading frame library ("ChromORFeome" library), we identify chromatin factors with putative roles in the DDR. Among these, we find the PHF20 factor is excluded from DNA breaks, affecting DNA repair by competing with 53BP1 recruitment. Adaptable for genetic perturbations, small-molecule screens, and large-scale analysis of DNA repair, these resources can aid our understanding and manipulation of DNA repair.

Indexed as

DNA DamageDNA RepairOpen Reading FramesChromatinDNA Repair EnzymesHigh-Throughput Screening AssaysHistonesHumansKineticsTumor Suppressor p53-Binding Protein 1ChromatinDNA Repair EnzymesHistonesTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1chromatin accessibilityDNA damage fociDNA repairGOFhigh throughputlaser microirradiationPHF20

Identifiers

PMID34965416
PMCPMC8763642
OpenAlexW4200246977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.